<--- Back to Details
First PageDocument Content
Pharmaceutical sciences / Pharmaceutical industry / Pharmacology / Food and Drug Administration / Clinical trial / Form FDA 483 / Clinical investigator / Investigational Device Exemption / Institutional review board / Research / Clinical research / Health
Date: 2013-02-19 10:32:47
Pharmaceutical sciences
Pharmaceutical industry
Pharmacology
Food and Drug Administration
Clinical trial
Form FDA 483
Clinical investigator
Investigational Device Exemption
Institutional review board
Research
Clinical research
Health

FDA Warning Letter to Solta Medical, Inc[removed]

Add to Reading List

Source URL: www.circare.org

Download Document from Source Website

File Size: 107,24 KB

Share Document on Facebook

Similar Documents

Institutional Review Board Wake Forest University – Reynolda Campus Certificate of Confidentiality Checklist Note: A Certificate of Confidentiality will not be issued to an applicant co

DocID: 1uZkR - View Document

Institutional Review Board . ... . .

DocID: 1ubXP - View Document

University of Pennsylvania  Institutional Review Board O Is IRB Review Required? The first question one should consider when assessing the requirement for IRB review is whether the activity meets the regulatory defini

DocID: 1tsSK - View Document

Reliance Memorandum of Understanding Between and Among the University of California Campuses, UC Division of Agriculture and Natural Resources, and Lawrence Berkeley National Laboratory for Institutional Review Board Rev

DocID: 1to8J - View Document

INSTITUTIONAL REVIEW BOARD HUMAN SUBJECTS RESEARCH DETERMINATION FORM Instructions: Complete this form to help determine if your project qualifies as research that involves the use of human participants. You are not r

DocID: 1tdGE - View Document